Dr. Reddy's Laboratories Tech Stack
Global pharmaceutical manufacturer delivering generics, APIs, and biosimilars
Dr. Reddy's is a 40-year-old public pharmaceutical company operating across APIs, generics, branded generics, biosimilars, and OTC products across six major markets (USA, India, Russia & CIS, China, Brazil, Europe). The tech stack reflects a manufacturing and supply-chain-first operation: SAP, LIMS, SCADA, HPLC, LC-MS, and Kinaxis RapidResponse dominate, with recent adoption of HMI signaling continued investment in production automation and real-time monitoring. Sales and marketing represent 62% of active hiring, while manufacturing and product teams lag—a pattern consistent with a commercial-execution challenge around new product launches and market share growth.
Tech Stack 24 technologies
What Dr. Reddy's Laboratories Is Building
◆Challenges
- Ensuring product availability
- Achieving market share targets
- Brand image enhancement
- Minimizing inventory write-offs
- Patent litigation management
- Product launch success
- Sales performance
- Identifying new product opportunities
- Managing territory data
- Industry disruption
▲Active Projects
- New products conceptualization and planning
- New product launch stock planning
- Ip due diligence
- Retail chemist prescription audit
- New products launch
- Launch activities for doctors, camps, cme sessions
- Hospital formulary integration
- Divisional initiatives such as conferences, speaker programs, and promotional events
- Monthly and quarterly rsm review presentations at the c-suite level
- Market access strategy
Hiring Activity
Department
Seniority
Notable leadership hires: Finance Head, Therapy Lead
